Pharmacology, Toxicology and Pharmaceutical Science
Abiraterone
100%
Castration Resistant Prostate Cancer
100%
Prostate Cancer
75%
Protein P53
75%
Neoplasm
62%
Mouse Model
37%
Genetically Engineered Mouse Strain
37%
Androgen Receptor
37%
Abiraterone Acetate
25%
Androgen
25%
Preclinical Study
12%
Enzalutamide
12%
Prevalence
12%
Overall Survival
12%
Synaptophysin
12%
Cancer Inhibition
12%
Malignant Neoplasm
12%
Tumor Growth
12%
Cancer Mortality
12%
Medicine and Dentistry
Castration Resistant Prostate Cancer
100%
Abiraterone
100%
Protein P53
75%
Prostate Cancer
62%
Neoplasm
50%
Androgen Receptor
37%
Abiraterone Acetate
25%
Androgen Synthesis
25%
Prevalence
12%
Malignant Neoplasm
12%
Synaptophysin
12%
Overall Survival
12%
Cancer Mortality
12%
Tumor Histology
12%
Enzalutamide
12%
Magnetic Resonance Imaging
12%
Immunohistochemistry
12%
Tumor Progression
12%
Prostate Cancer Cell Line
12%
Cancer Inhibition
12%
Xenograft
12%
Genome-Wide Analysis of Gene Expression
12%
Biochemistry, Genetics and Molecular Biology
P53
100%
Mouse Model
50%
Genetically Engineered Mouse Strain
50%
Androgen Receptor
50%
Androgen Synthesis
33%
Prevalence
16%
Synaptophysin
16%
Cancer Cell
16%
Overall Survival
16%
Tumor Volume
16%
Tumor Progression
16%
Preclinical Study
16%
Cancer Mortality
16%
Magnetic Resonance Imaging
16%
Enzalutamide
16%
Genome-Wide Analysis of Gene Expression
16%